The deal values the Swedish company at $1.2 billion, and the Biotage board recommended that shareholders accept the offer.

Private equity firm KKR (KKR) said Tuesday that it has made an offer to acquire all the shares in Swedish life sciences group ...

KKR & Co. Inc. closed 42.52% below its 52-week high of $170.40, which the company achieved on January 31st.

Shares of KKR & Co. Inc. KKR rose 1.29% to $103.37 Thursday, on what proved to be an all-around mixed trading session for the ...

The correction being experienced comes on the backdrop of billionaire investor Prem Watsa insisting that value investing has ...

The firm, which has once again topped the latest AmLaw 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

KKR & Co. remains a top-tier firm, but its volatile stock, dilution risk, and economic sensitivity warrant caution. Check out ...

Sweden's Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 ...

Private equity firm KKR & Co. made an offer to acquire all the shares in Swedish life sciences group Biotage AB for 11.6 ...

Barclays Plc, Citigroup Inc. and KKR Capital Markets are underwriting approximately $1.7 billion in debt to support KKR’s ...

KKR and I Squared Capital are among global asset managers bidding for a district cooling business owned by Abu Dhabi's ...

Shares in private equity giant KKR (KKR) were higher today after it made a $1.2 billion takeover offer for Swedish biotechnology company ...